Mizuho Securities Reaffirms Their Buy Rating on Neumora Therapeutics, Inc. (NMRA)
Mizuho Securities analyst Graig Suvannavejh maintained a Buy rating on Neumora Therapeutics, Inc. (NMRA – Research Report) today and set a ...
Humana Completes Aggregate $1.25 Billion Debt Offering
Humana Inc. (the "company") (NYSE: HUM) announced today the completion of its public offering of $1.25 billion in aggregate ...
Mizuho Boosts PENN Entertainment (NASDAQ:PENN) Price Target to $25.00
PENN Entertainment (NASDAQ:PENN – Free Report) had its price objective raised by Mizuho from $24.00 to $25.00 in a research ...
Hubbell Incorporated (NYSE:HUBB) Short Interest Up 28.3% in February
Hubbell Incorporated (NYSE:HUBB – Get Free Report) was the target of a large growth in short interest in February. As of February 15th, there was short interest totalling 2,040,000 shares, a growth of ...